The National Institute for Health and Care Excellence (NICE) has rejected the Alzheimer’s drug donanemab because the ...
A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...
Britain's drug regulator approved the Alzheimer's drug Kisunla on Wednesday, but the government won't be paying for it after an independent watchdog agency said the treatment isn't worth the cost to ...